SCHEMBL3564741

SCHEMBL3564741

CC(C)(Oc1ccc(Cl)cc1)C(=O)Nc1cc(C2C[CH]C2)n[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2C19 P33261 3/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2D6 P10635 2/20 0.51
ALDH1A1 P00352 1/20 0.51
ADORA3 P0DMS8 1/20 0.50
ADORA2A P29274 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.46
PPARA Q07869 3/20 0.45
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
RECQL P46063 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HSD11B1 P28845 4/20 0.44
HSD11B2 P80365 3/20 0.44
POLB P06746 1/20 0.42
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388500 0.86 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL6388495 0.86 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL3557551 0.83 FFAR2 (0.46) CYP3A4CYP2C19MAPTGAAHSD11B1
SCHEMBL3260157 0.81 ADORA1 (0.39) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL6386704 0.75 HSD11B1 (0.52) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL6386700 0.74 HSD11B1 (0.49) ALDH1A1ADORA3ADORA2AL3MBTL1HSD11B1
SCHEMBL2610067 0.71 CYP1A2 (0.81) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL3244773 0.71 ALDH1A1 (0.35) CYP2C19CYP2D6ALDH1A1ADORA3ADORA2A
SCHEMBL19248207 0.69 ALDH1A1 (0.64) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL5868003 0.69 CCNA2 (0.56) CYP3A4MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7671072-B2 Aminopyrazole derivatives as GSK-3 inhibitors PFIZER INC. (US) 2010-03-02 US disclosed
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors BENBOW JOHN W 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276010-A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors GSK3B, GSK3A, GSKIP CYP1A2 237/4885CYP3A4 460/4885CYP2C19 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.